RMTI Rockwell Medical
- 1.6000
- -0.0400-2.44%
Rockwell Medical News
Rockwell Medical Announced Product Purchase Agreement With US Health Systems In The Mountain West Region To Supply Its Liquid And Dry Acid And Bicarbonate Hemodialysis Concentrates, Cleaning Agents, And Hemodialysis Concentrates Mixers
Rockwell Medical Announced Product Purchase Agreement With US Health Systems In The Mountain West Region To Supply Its Liquid And Dry Acid And Bicarbonate Hemodialysis Concentrates, Cleaning Agents, A
Rockwell Medical Continues to Expand Its Distribution Capabilities in Western United States
Enters into new direct supply agreement with one of the largest health systems in the Mountain West Region Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops,
Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
Rockwell Medical Gains as Global Reach Widens
Rockwell Medical Enters New And Expanded Distribution Agreement With BioNuclear And Atlantic Medical International
In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the Company. The amended distribution agreement between Rockwell Medical and AMI expands the
Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda
New and expanded distribution agreements expected to generate approximately $1 million in annual revenues for Rockwell Medical Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that
Rockwell Medical (RMTI) Increases Despite Market Slip: Here's What You Need to Know
Rockwell Medical Is Maintained at Buy by HC Wainwright & Co.
Rockwell Medical Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Rockwell Medical, Lowers Price Target to $9
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price target from $11 to $9.
Rockwell Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/25/2024 414.29% HC Wainwright & Co. $11 → $9 Maintains Buy 11/15/2023 528.57% HC Wainwright & Co. → $11
Rockwell Medical Named 'Great Place to Work' for Second Year in a Row
Rockwell Medical, Inc. (the "Company") (NASDAQ:RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today
Analysts Have Been Trimming Their Rockwell Medical, Inc. (NASDAQ:RMTI) Price Target After Its Latest Report
There's No Escaping Rockwell Medical, Inc.'s (NASDAQ:RMTI) Muted Revenues Despite A 33% Share Price Rise
Those holding Rockwell Medical, Inc. (NASDAQ:RMTI) shares would be relieved that the share price has rebounded 33% in the last thirty days, but it needs to keep going to repair the recent damage it ha
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSalarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) sha
Earnings Call Summary | Rockwell Medical(RMTI.US) Q4 2023 Earnings Conference
The following is a summary of the Rockwell Medical, Inc. (RMTI) Q4 2023 Earnings Call Transcript:Financial Performance:Rockwell Medical achieved profitability for the first time on an adjusted EBITDA
Rockwell Medical Unveils Updated Corporate Insight Presentation
Earnings Scheduled For March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. • InflaRx (NASDAQ:IFRX) is projected to
Rockwell Medical Projects Net Sales To Grow In The Mid-to-high Single Digits In 2025 And Beyond And Projects Gross Margin In 2025 To Be Approximately 20% And Reach Above 25% In 2026 And Beyond
Rockwell Medical Projects Net Sales To Grow In The Mid-to-high Single Digits In 2025 And Beyond And Projects Gross Margin In 2025 To Be Approximately 20% And Reach Above 25% In 2026 And Beyond
Rockwell Medical: Q4 Earnings Insights
Rockwell Medical (NASDAQ:RMTI) reported its Q4 earnings results on Thursday, March 21, 2024 at 06:00 AM.Here's what investors need to know about the announcement.EarningsRockwell Medical beat estimate
Analysis
Price Target
No Data
